Search bioRxiv⌕ Search

bioRxiv · 10.1101/2021.09.29.462332

Cytokinin regulates energy utilization in Botrytis cinerea

Abstract

The plant hormone cytokinin (CK) is an important developmental regulator, promoting morphogenesis and delaying senescence. Previous work by us and others has demonstrated that CKs also mediate plant immunity and disease resistance. Some phytopathogens have been reported to secrete CKs, and may manipulate CK signaling to regulate the host cell cycle and nutrient allocation, to improve their pathogenic abilities. In a recent work, we demonstrated that CK directly inhibits the growth, development, and virulence of fungal phytopathogens, by down regulating the cell cycle and reducing cytoskeleton organization and cellular trafficking in the fungus. Here, focusing on Botrytis cinerea (Bc), we report that the effect of CK on Bc is tied to nutrient availability; CK strongly inhibits Bc growth and de-regulated cytoskeleton organization in a nutrient rich environment, but has a diminished effect when nutrients are scarce. Using biochemical assays and transgenic redox sensitive botrytis lines, we examined the effect of CK on energy consumption in the fungus, and demonstrate that CK promotes glycolysis and energy consumption in Bc, both in vitro and in planta. Here, glycolysis and increased oxidation were stronger with waning nutrient availability. Transcriptomic data further supports our findings, demonstrating significant upregulation to glycolysis, oxidative phosphorylation, and sucrose metabolism, upon CK treatment. The metabolic effects of CK on the fungus likely reflect the role of plant CK during early infection by necrotrophic pathogens, which are known to have an initial, short biotrophic phase. In addition to the plant producing CK during its interaction with the pathogen for defense priming and pathogen inhibition, the pathogen may take advantage of this increased CK to boost its metabolism and energy production, in preparation for the necrotrophic phase of the infection. Thus, the role of CK in controlling senescence can be exploited by diverse phytopathogens to their advantage. Author summaryCytokinin (CK) is one of the primary plant developmental hormones, regulating many developmental processes. Several works have highlighted the involvement of CK in plant defense. We recently reported that CK can directly inhibit fungal plant pathogens. CK inhibits Botrytis cinerea growth by arresting the cell cycle and de-regulating cytoskeleton organization and cellular trafficking. Here, we report that CK positively regulates B. cinerea energy consumption, causing an increase in glycolytic rates and energy consumption. The effect of CK on B. cinerea was dependent on nutrient availability, with CK causing stronger increases in glycolysis and lower growth inhibition when nutrient availably was low, and weaker glycolytic increases coupled with stronger growth inhibition in a high nutrient environment. We propose that CK can be viewed as a bidirectional signaling molecule in plant pathogen interactions: CK acts as a signal to the fungus that plant tissue is present, causing it to activate sugar and energy metabolism pathways to take advantage of the available food source, while at the same time, CK is employed by the plant to inhibit the attacking pathogen.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Anand, G., Gupta, R., Bar, M.. 2021-09-29. Cytokinin regulates energy utilization in Botrytis cinerea. https://doi.org/10.1101/2021.09.29.462332

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗